OrbiMed

Sobre

OrbiMed invests globally across health care, from seed-stage startups to large public companies. Its private-equity strategy backs biopharmaceutical, medical-device, diagnostic, health-care-service, and digital-health companies and typically acts as a lead investor.

Sectores

• Ciencias de la vida
• Salud / Salud digital

Inversiones destacadas

• Insmed
• Emergent BioSolutions
• Myriad Genetics
• Crinetics Pharmaceuticals
• Corvus Pharmaceuticals
• Adicet Bio
• Keros Therapeutics

Inversores

• Sven H. BorhoManaging Partner→
• Carl L. GordonManaging Partner→
• W. Carter NeildManaging Partner→
• Geoffrey C. HsuGeneral Partner→
• C. Scotland StevensGeneral Partner→
• David BonitaGeneral Partner→
• Matthew RizzoGeneral Partner→
• Peter ThompsonGeneral Partner→
• Mona AshiyaGeneral Partner→

Cómo contactarlos

info@orbimed.com